3,066
Views
21
CrossRef citations to date
0
Altmetric
Antimicrobial Agents

Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance

, , , , , , , , & show all
Pages 703-714 | Received 30 Nov 2021, Accepted 23 Jan 2022, Published online: 01 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chin Fen Neoh, Wirawan Jeong, David CM Kong & Monica A Slavin. (2023) The antifungal pipeline for invasive fungal diseases: what does the future hold?. Expert Review of Anti-infective Therapy 21:6, pages 577-594.
Read now

Articles from other publishers (20)

Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, Roger Brüggemann, Agostinho Carvalho, Tom Chiller, Sharon Chen, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A. W. Gold, Andreas H. Groll, Jannes Heylen, Jeffrey D. Jenks, Robert Krause, Katrien Lagrou, Frédéric Lamoth, Juergen Prattes, Sarah Sedik, Joost Wauters, Nathan P. Wiederhold & George R. ThompsonIIIIII. (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical Microbiology Reviews.
Crossref
Emily Puumala, David Sychantha, Elizabeth Lach, Shawn Reeves, Sunna Nabeela, Meea Fogal, AkshatKumar Nigam, Jarrod W. Johnson, Alán Aspuru-Guzik, Rebecca S. Shapiro, Priya Uppuluri, Subha Kalyaanamoorthy, Jakob Magolan, Luke Whitesell, Nicole Robbins, Gerard D. Wright & Leah E. Cowen. (2024) Allosteric inhibition of tRNA synthetase Gln4 by N-pyrimidinyl-β-thiophenylacrylamides exerts highly selective antifungal activity. Cell Chemical Biology 31:4, pages 760-775.e17.
Crossref
Chin Fen Neoh, Sharon C-A Chen, Fanny Lanternier, Shio Yen Tio, Catriona L. Halliday, Sarah E. Kidd, David C. M. Kong, Wieland Meyer, Martin Hoenigl & Monica A. Slavin. (2024) Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections. Clinical Microbiology Reviews.
Crossref
Emily Puumala, Sara Fallah, Nicole Robbins & Leah E. Cowen. (2024) Advancements and challenges in antifungal therapeutic development. Clinical Microbiology Reviews 37:1.
Crossref
Lisa Kriegl, Matthias Egger, Johannes Boyer, Martin Hoenigl & Robert Krause. (2024) New treatment options for critically important WHO fungal priority pathogens. Clinical Microbiology and Infection.
Crossref
Matheus de Castro Leitão, Hugo Lins de Albuquerque Vieira, Larissa Fernandes, Ildinete Silva-Pereira & Cíntia Marques Coelho. 2024. CRISPR-Cas System in Translational Biotechnology. CRISPR-Cas System in Translational Biotechnology 191 205 .
Norman van Rhijn, Isabelle S. R. Storer, Mike Birch, Jason D. Oliver, Michael J. Bottery & Michael J. Bromley. (2023) Aspergillus fumigatus strains that evolve resistance to the agrochemical fungicide ipflufenoquin in vitro are also resistant to olorofim. Nature Microbiology 9:1, pages 29-34.
Crossref
Corinne Pinder, Ressa Lebedinec, Tim P. Levine, Mike Birch & Jason D. Oliver. (2023) Characterisation of putative class 1A DHODH-like proteins from Mucorales and dematiaceous mould species. PLOS ONE 18:8, pages e0289441.
Crossref
Victor Michel, Nizar Mahlaoui, Marie Elisabeth Bougnoux, Dea Garcia-Hermoso, Fanny Lanternier & Romain Lévy. (2023) Prolonged Remission of Azole-Resistant Lung Aspergillosis with Olorofim, in an Adolescent with X-Linked Chronic Granulomatous Disease. Journal of Clinical Immunology 43:6, pages 1170-1172.
Crossref
Iacopo Franconi, Cosmeri Rizzato, Noemi Poma, Arianna Tavanti & Antonella Lupetti. (2023) Candida parapsilosis Sensu Stricto Antifungal Resistance Mechanisms and Associated Epidemiology. Journal of Fungi 9:8, pages 798.
Crossref
Hideo Ishii. (2023) New chemical fungicides in relation to risk for resistance development. Tropical Plant Pathology 49:1, pages 18-35.
Crossref
Amanda Bombassaro, Bram Spruijtenburg, Fernanda Medeiros, Bruna Jacomel Favoreto de Souza Lima, Luana Beatriz Ballardin, Marconi Rodrigues de Farias, Vania Aparecida Vicente, Flavio de Queiroz‐Telles, Jacques F. Meis & Theun de Groot. (2023) Genotyping and antifungal susceptibility testing of Sporothrix brasiliensis isolates from Southern Brazil . Mycoses 66:7, pages 585-593.
Crossref
Cléa Melenotte, Vishukumar Aimanianda, Monica Slavin, José María Aguado, Darius Armstrong‐James, Yee‐Chun Chen, Shahid Husain, Christian Van Delden, Faouzi Saliba, Agnès Lefort, Francoise Botterel & Olivier Lortholary. (2023) Invasive aspergillosis in liver transplant recipients. Transplant Infectious Disease 25:3.
Crossref
Paloma Osset-Trénor, Amparo Pascual-Ahuir & Markus Proft. (2023) Fungal Drug Response and Antimicrobial Resistance. Journal of Fungi 9:5, pages 565.
Crossref
Ricardo Cruz & William M. Wuest. (2023) Beyond ergosterol: Strategies for combatting antifungal resistance in Aspergillus fumigatus and Candida auris. Tetrahedron 133, pages 133268.
Crossref
Norman van Rhijn, Sam Hemmings, Isabelle S. R. Storer, Clara Valero, Hajer Bin Shuraym, Gustavo H. Goldman, Fabio Gsaller, Jorge Amich & Michael J. Bromley. (2022) Antagonism of the Azoles to Olorofim and Cross-Resistance Are Governed by Linked Transcriptional Networks in Aspergillus fumigatus. mBio 13:6.
Crossref
Pilar Escribano, Ana Gómez, Elena Reigadas, Patricia Muñoz & Jesús Guinea. (2022) EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings. Antimicrobial Agents and Chemotherapy 66:9.
Crossref
Neil A. R. Gow, Carolyn Johnson, Judith Berman, Alix T. Coste, Christina A. Cuomo, David S. Perlin, Tihana Bicanic, Thomas S. Harrison, Nathan Wiederhold, Mike Bromley, Tom Chiller & Keegan Edgar. (2022) The importance of antimicrobial resistance in medical mycology. Nature Communications 13:1.
Crossref
Pilar Escribano, Ana Gómez, Elena Reigadas, Patricia Muñoz & Jesús Guinea. (2022) In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B. Clinical Microbiology and Infection 28:9, pages 1291.e7-1291.e10.
Crossref
Nathan P. Wiederhold. (2022) Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents. Journal of Fungi 8:8, pages 857.
Crossref